| 參考文獻 |
參考文獻
Abreu JG, Ketpura NI, Reversade B, De Robertis EM: Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-beta. Nat Cell Biol 2002; 4(8): 599-604.
Aliprantis AO, Yang RB, Weiss DS, Godowski P, Zychlinsky A: The apoptotic signaling pathway activated by Toll-like receptor-2. EMBO J 2000; 19(13): 3325-36.
Angele P, Yoo JU, Smith C, Mansour J, Jepsen KJ, Nerlich M, Johnstone B: Cyclic hydrostatic pressure enhances the chondrogenic phenotype of human mesenchymal progenitor cells differentiated in vitro. J Orthop Res 2003, 21(3):451-457.
Au JL, Badalament RA, Wientjes MG, Young DC, Warner JA, Venema PL, Pollifrone DL, Harbrecht JD, Chin JL, Lerner SP : Methods to improve efficacy of intravesical mitomycin C: results of a randomized phase III trial. J Natl Cancer Inst 2001, 93(8):597-604.
Blaveri E, Simko JP, Korkola JE, Brewer JL, Baehner F, Mehta K : Bladder cancer outcome and subtype classification by gene xpression. Clin Cancer Res 2005; 11(11): 4044-55.
Birare N, Lwaleed BA, Cooper AJ: Multidrug resistance in a urothelial cancer cell line after 1-hour mitomycin C exposure. J Urol 2009; 182(5): 2472-6.
Brown V, Brown RA, Ozinsky A, Hesselberth JR, Fields S: Binding specificity of Toll-like receptor cytoplasmic domains. Eur J Immunol 2006; 36(3): 742-53.
Carver SE, Heath CA: Semi-continuous perfusion system for delivering intermittent physiological pressure to regenerating cartilage. Tissue Engineering 1999; 5, 1-11.
Chang ML, Yeh CT, Chen JC, Huang CC, Lin SM, Sheen IS: Altered expression patterns of lipid metabolism genes in an animal model of HCV core-related, nonobese, modest hepatic steatosis. BMC Genomics 2008; 9: 109.
Chen SK, Chung CA, Cheng YC, Huang CJ, Ruaan RC, Chen WY, Li C, Tsao CW, Hu WW, Chien CC : Hydrostatic pressure enhances mitomycin C- induced apoptosis in urothelial carcinoma cells. Urologic Oncology: Seminars and Original Investigations 2014; 26e17-26e24.
Chiang HS, Guo HR, Hong CL, Lin SM, Lee EF: The incidence of bladder cancer in the black foot disease endemic area in Taiwan. Br J Urol 1993, 71(3):274-278.
Cliff AM, Heatherwick B, Scoble J, Parr NJ: The effect of fasting or
desmopressin before treatment on the concentration of mitomycin C
during intravesical administration. BJU Int 2000, 86(6):644-647.
Colombo R, Lev A, Da Pozzo LF, Freschi M, gallus G, Rigatti P: A new approach using local combined microwave hyperthermia and chemotherapy in superficial transitional bladder carcinoma treatment. J Urol 1995; 153:959-963
Colombo R, Brausi M, Da Pozzo L, Salonia A, Montorsi F, Scattoni V,
Roscigno M, Rigatti P: Thermo-chemotherapy and electromotive drug
administration of mitomycin C in superficial bladder cancer eradication. a pilot study on marker lesion. Eur Urol 2001, 39(1):95-100.
Colombo R, Da Pozzo LF, Salonia A, Rigatti P, Leib Z, Baniel J, Caldarera E, Pavone-Macaluso M: Multicentric study comparing intravesical chemotherapy alone and with local microwave hyperthermia for prophylaxis of recurrence of superficial transitional cell carcinoma. J Clin Oncol 2003, 21(23):4270-4276.
Crapo PM, Wang Y: Hydrostatic pressure independently increases elastin and collagen co-expression in small-diameter engineered arterial constructs. J Biomed Mater Res A 2011, 96(4):673-681.
Croci S, Landuzzi L, Astolfi A, Nicoletti G, Rosolen A, Sartori F : Inhibition of connective tissue growth factor (CTGF/CCN2) expression decreases the survival and myogenic differentiation of human rhabdomyosarcoma cells. Cancer Res 2004; 64(5): 1730-6.
Eguchi T, Kubota S, Kawata K, Mukudai Y, Uehara J, Ohgawara T : Novel transcription-factor-like function of human matrix metalloproteinase 3 regulating the CTGF/CCN2 gene. Mol Cell Biol 2008; 28(7): 2391-413.
Farhat K, Riekenberg S, Heine H, Debarry J, Lang R, Mages J: Heterodimerization of TLR2 with TLR1 or TLR6 expands the ligand spectrum but does not lead to differential signaling. J Leukoc Biol 2008; 83(3): 692-701.
Frank HN, Matthew BD, Alister B: 1977 The CIBA Collection of Medical Illustrations Vol. 6, 24-27, 211
Fremond CM, Yeremeev V, Nicolle DM, Jacobs M, Quesniaux VF, Ryffel B: Fatal Mycobacterium tuberculosis infection despite adaptive immune response in the absence of MyD88. J Clin Invest 2004; 114(12): 1790-9.
Frithjof H: 1980. Sobotta/Hammersen Histology, 154-155
Grotendorst GR: Connective tissue growth factor: a mediator of TGF-beta action on fibroblasts. Cytokine Growth Factor Rev 1997; 8(3): 171-9.
Haasler T, Homann G, Duong DTA, Jungling E, Westhofen M, Luckhoff A: Pharmacological modulation of transmitter release by inhibition of pressure-dependent potassium currents in vestibular hair cells. Naunyn Schmiedebergs Arch Pharmacol 2009, 80(6):531-538.
Hahn GM: Potential for therapy of drugs and hyperthermia. Cancer Res 1979; 39: 2264-2268.
Hammami S, Willumsen NJ, Olsen HL, Morera FJ, Latorre R, Klaerke DA: Cell volume and membrane stretch independently control K+ channel activity. J Physiol 2009, 587(Pt 10):2225-2231.
Hausladen DA, Wheeler MA, Altieri DC, Colberg JW, Weiss RM: Effect of intravesical treatment of transitional cell carcinoma with bacillus
Calmette-Guerin and mitomycin C on urinary survivin levels and
outcome. J Urol 2003, 170(1):230-234.
Hirose K, Imao S, Akaza H, Shiokawa E, Seto T: Hydrostatic pressure
treatment for the bladder cancer (The 3rd report) (author′s transl).
Nihon Hinyokika Gakkai Zasshi 1976, 67(8):601-614.
Hishikawa K, Oemar BS, Tanner FC, Nakaki T, Luscher TF, Fujii T: Connective tissue growth factor induces apoptosis in human breast cancer cell line MCF-7. J Biol Chem 1999; 274(52): 37461-6.
Hülya B , Valerian EK: Bench-to-bedside review: Mitochondrial injury, oxidative stress and apoptosis – there is nothing more practical than a good theory, Critical Care 2008, 12:206
Into T, Kiura K, Yasuda M, Kataoka H, Inoue N, Hasebe A, Takeda K, Akira S, Shibata K: Stimulation of human Toll-like receptor (TLR) 2 and TLR6 with membrane lipoproteins of Mycoplasma fermentans induces apoptotic cell death after NF-kappa B activation. Cell Microbiol 2004.6, 187.
Jewett MAS, Aaron JB, Wu HM, Lou TJ: MCCQE 2000 Review Notes and Lecture Series Urology, 12, Fig-2
Jin MS, Kim SE, Heo JY, Lee ME, Kim HM, Paik SG : Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide. Cell 2007; 130(6): 1071-82.
Joyner DE, Jones KB, Lessnick SL, Schiffman JD, Randall RL: Potential for modulation of the fas apoptotic pathway by epidermal growth factor in sarcomas. Sarcoma; 2011: 847409.
Jurgen Sokeland, Urology A Pocket Reference, 1989, 147
Kang YH, Lee KA, Ryu CJ, Lee HG, Lim JS, Park SN, Paik SG, Yoon DY: Lamm DL: Efficacy and safety of bacille Calmette-Guerin immunotherapy in superficial bladder cancer. Clin Infect Dis 2000, 31 Suppl 3:S86-90.
Kang YH, Lee KA, Ryu CJ, Lee HG, Lim JS, Park SN, Paik SG, Yoon DY: Mitomycin C induces apoptosis via Fas/FasL dependent pathway and suppression of IL-18 in cervical carcinoma cells. Cancer Lett 2006, 237(1):33-44.
Kasten A, Muller P, Bulnheim U, Groll J, Bruellhoff K, Beck U, Steinhoff G, Moller M, Rychly J: Mechanical integrin stress and magnetic forces induce biological responses in mesenchymal stem cells which depend on environmental factors. J Cell Biochem 2010, 111(6):1586-1597.
Kaufman DS, Shipley WU, Feldman AS: Bladder cancer. Lancet 2009,
374(9685):239-249.
Klukas C, Schreiber F: Dynamic exploration and editing of KEGG pathway diagrams. Bioinformatics 2007; 23(3): 344-50.
Konstantinos NS, Donald GS: Bladder Cancer Biology, Diagnosis, and management, 1999,306, Fig22.2
Knothe UR, Dolejs S, Matthew Miller R, Knothe Tate ML: Effects of
mechanical loading patterns, bone graft, and proximity to periosteum on bone defect healing. J Biomech 2010, 43(14):2728-2737.
Lamm DL: Efficacy and safety of bacille Calmette-Guerin immu- notherapy in superficial bladder cancer. Clin Infect Dis 2000; 31(Suppl. 3):S86–90.
Lane TF, Sage EH: The biology of SPARC, a protein that modulates cell-matrix interactions. FASEB J 1994; 8(2): 163-73.
Larson J, Yasmin T, Sens DA, Zhou XD, Sens MA, Garrett SH : SPARC gene expression is repressed in human urothelial cells (UROtsa) exposed to or malignantly transformed by cadmium or arsenite. Toxicol Lett 2010; 199(2): 166-72.
Lin SC, Lo YC, Wu H: Helical assembly in the MyD88-IRAK4-IRAK2 complex in TLR/IL-1R signalling. Nature 2010; 465(7300): 885-90.
Loiarro M, Gallo G, Fanto N, De Santis R, Carminati P, Ruggiero V : Identification of critical residues of the MyD88 death domain involved in the recruitment of downstream kinases. J Biol Chem 2009; 284(41): 28093-103.
Lopez BA, Requena MJ, Cheng L, Montironi R: Pathological variants of invasive bladder cancer according to their suggested clinical significance. BJU Int 2008, 101(3):275-281.
Macdonald AG, Martinac B: Effect of high hydrostatic pressure on the
bacterial mechanosensitive channel MscS. Eur Biophys J 2005,
34(5):434-441.
Mandal A, Shahidullah M, Delamere NA: Hydrostatic pressure-induced release of stored calcium in cultured rat optic nerve head astrocytes. Invest Ophthalmol Vis Sci 2010, 51(6):3129-3138.
Massey JA, Abrams PH: Obstructed voiding in the female. Br J Urol 1988, 61(1):36-39.
Masuda T, Takahashi I, Anada T, Arai F, Fukuda T, Takano-Yamamoto T, Suzuki O: Development of a cell culture system loading cyclic mechanical strain to chondrogenic cells. J Biotechnol 2008, 133(2):231-238.
Matika CA, Wasilewski M, Arnott JA, Planey SL: Antiproliferative factor regulates connective tissue growth factor (CTGF/CCN2) expression in T24 bladder carcinoma cells. Mol Biol Cell 2012; 23(10): 1976-85.
McDowall MD, Scott MS, Barton GJ: human protein-protein interaction prediction database. Nucleic Acids Res 2009; 37(Database issue): D651-6.
Mishina T, Oda K, Murata S, Ooe H, Mori Y: Mitomycin C bladder
instillation therapy for bladder tumors. J Urol 1975, 114(2):217-219.
Mitra AP, Cote RJ: Molecular pathogenesis and diagnostics of bladder cancer. Annu Rev Pathol 2009; 4: 251-85.
Mizuno S, Tateishi T, Ushida T, Glowacki J: Hydrostatic fluid pressure enhances matrix synthesis and accumulation by bovine chondrocytes in three-dimensional culture. Journal of Cellular Physiology 2002; 193, 319-327.
Mok SC, Chan WY, Wong KK, Muto MG, Berkowitz RS: SPARC, an extracellular matrix protein with tumor-suppressing activity in human ovarian epithelial cells. Oncogene 1996; 12(9): 1895-901.
Nagatomi J, Arulanandam BP, Meunier A, Bizios R: Effect of cyclic pressure on bone marrow cell cultures. Journal of Biomechanical Engineering 2002; 124, 308-314.
Nativ O, Witjes JA, Hendricksen K, Cohen M, Kedar D, Sidi A : Combined thermo-chemotherapy for recurrent bladder cancer after bacillus Calmette-Guerin. J Urol 2009; 182(4): 1313-7.
Parkin DM, Bray F, Ferlay J, Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 2005; 55(2): 74-108.
Petrov E, Rohde PR, Martinac B: Flying-patch patch-clamp study of
G22E-MscL mutant under high hydrostatic pressure. Biophys J 2011,
100(7):1635-1641.
Reza AT, Nicoll SB: Hydrostatic pressure differentially regulates outer and inner annulus fibrosus cell matrix production in 3D scaffolds. Ann Biomed Eng 2008, 36(2):204-213.
Rischmann P, Desgrandchamps F, Malavaud B, Chopin DK: BCG
intravesical instillations: recommendations for side-effects anagement. Eur Urol 2000, 37 Suppl 1:33-36.
Rita P, Andrea S, Avigdor L, Luigi F, Da P, Giuliana C, Francesco M, Patrizio R, Renzo C: Effect of local hyperthermia of the bladder on mitomycin C pharmacokinetics durnig intravesical chemotherapy for the treatment of superficial transitional cell carcinoma. Br J Clin Pharmacol 2001, 52, 273-278
Tyritzis SI, Stravodimos KG, Mihalakis A, Constantinides CA : Complications associated with primary and secondary perforation of the bladder following immediate instillations of epirubicin after transurethral resection of superficial urothelial tumours. Int Urol Nephrol 2009; 41(4): 865-8.
Saadat SH, Al-Tawil MO: Risk factors for disconcordance between pre and post radical cystectomy stages. Urol J 2011, 8(4):291-297
Said MT, Abomelha MS, Orkubi SA: Intravesical immunotherapy for
superficial bladder cancer. Saudi Med J 2002, 23(12):1458-1461.
Scanga CA, Bafica A, Feng CG, Cheever AW, Hieny S, Sher A: MyD88-deficient mice display a profound loss in resistance to Mycobacterium tuberculosis associated with partially impaired Th1 cytokine and nitric oxide synthase 2 expression. Infect Immun 2004; 72(4): 2400-4.
Schumann D, Kujat R, Nerlich M, Angele P: Mechanobiological
conditioning of stem cells for cartilage tissue engineering. Biomed Mater Eng 2006, 16(4 Suppl):S37-52.
Scott MS, Barton GJ: Probabilistic prediction and ranking of human protein-protein interactions. BMC Bioinformatics 2007; 8: 239.
Simpson GR, Horvath A, Annels NE, Pencavel T, Metcalf S, Seth R, Peschard P, Price T, Coffin RS, Mostafid H: Combination of a fusogenic glycoprotein, pro-drug activation and oncolytic HSV as an intravesical therapy for superficial bladder cancer. Br J Cancer 2012, 106(3):496-507.
Speers AG, Lwaleed BA, Featherstone JM, Cooper AJ: Multidrug resistance in a urothelial cancer cell line after 3, 1-hour exposures to mitomycin C. J Urol 2007; 178(5): 2171-5.
Sprick MR, Weigand MA, Rieser E, Rauch CT, Juo P, Blenis J: FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2. Immunity 2000; 12(6): 599-609.
Stasi DSM, Giannantoni A, Stephen RL, Capelli G, Navarra P, Massoud R, Vespasiani G: Intravesical electromotive mitomycin C versus passive transport mitomycin C for high risk superficial bladder cancer: a prospective randomized study. J Urol 2003, 170(3):777-782.
Stasi DSM, Liberati E, Dutto L, Verri C: Intravesical electromotive drug administration of mitomycin-C for non-muscle invasive bladder cancer. Arch Ital Urol Androl 2008; 80(4): 157-61.
Stephen BE, David RB, Carolyn CC, April GF, Frederick LG, Andy T III: AJCC Cancer Staging Manual 7th Editiion. 2010
Susan Elmore: Apoptosis: A Review of Programmed Cell Death. Toxicol Pathol. 2007; 35(4):495-516
Sylvester RJ, van der MA, Lamm DL: Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials. J Urol 2002; 168(5): 1964-70.
Sylvester RJ, Oosterlinck W, van der Meijden AP: A single immediate
postoperative instillation of chemotherapy decreases the risk of
recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials. J Urol 2004, 171(6 Pt 1):2186-2190, quiz 2435.
Takeda K, Akira S: Toll-like receptors in innate immunity. International Immunology 2005; 17(1): 1-14.
Tanaka MF, Sonpavde G: Diagnosis and management of urothelial
carcinoma of the bladder. Postgrad Med 2011, 123(3):43-55.
Van der Heijden AG, Hulsbergen-Van de KC, Witjes JA: The influence of thermo-chemotherapy on bladder tumours: an immunohistochemical analysis. World J Urol 2007; 25(3): 303-8.
Wagrell L, Schelin S, Bolmsjo M, Brudin L: Intraprostatic temperature
monitoring during transurethral microwave thermotherapy for the
treatment of benign prostatic hyperplasia. J Urol 1998, 159(5):1583-1587.
Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA: Campbell-Walsh Urology 9th edition, 2007, 2410-2416, 2565, 2609
Wikipedia; apoptosis
Yang C, Huang C-H, Cheong M-L, Hung K-L, Lin L-H, Yu Y-S: Unambiguous molecular detections with multiple genetic approach for the complicated chromosome 22q11 deletion syndrome. BMC Medical Genetics 2009; 10(1): 16.
Yeo B: MIMS 41th Edition Taiwan Index of Medical Specialities, 2010, 170-171.
Zhang Z, Furge KA, Yang XJ, Teh BT, Hansel DE: Comparative gene expression profiling analysis of urothelial carcinoma of the renal pelvis and bladder. BMC Med Genomics 2010; 3: 58.
Zhang XZ, Yin AH, Lin DJ, Zhu XY, Ding Q, Wang CH: Analyzing gene expression profile in K562 cells exposed to sodium valproate using microarray combined with the connectivity map database. J Biomed Biotechnol; 2012: 654291.
余明翰，2012，靜水壓對細胞分化及增生影響的實驗研究，中央大學機械工程學系碩士論文。
|
[Endnote RIS 格式]
[相關文章]
[文章引用]
[完整記錄]
[館藏目錄]
[檢視]
plurk
funp
live
udn
HD
myshare
netvibes
friend
youpush
delicious
baidu
Google bookmarks
del.icio.us
hemidemi
facebook
twitter
google
reddit